Janick Selves

Toulouse, 31000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Corrigendum to "Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis" The Lancet Regional Health - Europe, Volume 60, January 2026, 101524.

Corrigendum to "Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis" The Lancet Regional Health - Europe, Volume 60, January 2026, 101524.

Journal: The Lancet regional health. Europe

Published: July 30, 2026

Baseline circulating and tumor γδ T cells and early circulating CD8⁺PD1⁺ expansion predict response to Atezolizumab-bevacizumab in HCC.

Baseline circulating and tumor γδ T cells and early circulating CD8⁺PD1⁺ expansion predict response to Atezolizumab-bevacizumab in HCC.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 24, 2026

Is survival influenced by metastatic site in synchronous metastatic pancreatic adenocarcinoma (PDAC)? A prospective real-world BACAP study.

Is survival influenced by metastatic site in synchronous metastatic pancreatic adenocarcinoma (PDAC)? A prospective real-world BACAP study.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

A deceptively benign biliary lesion revealing an ALK-rearranged intrahepatic cholangiocarcinoma.

A deceptively benign biliary lesion revealing an ALK-rearranged intrahepatic cholangiocarcinoma.

Journal: Histopathology

Published: January 27, 2026

Do not underestimate cryptosporidium: case report of a rare cause of acute liver failure in transplant recipients.

Do not underestimate cryptosporidium: case report of a rare cause of acute liver failure in transplant recipients.

Journal: BMC infectious diseases

Published: January 23, 2026

From clusters to clinic: An 8-gene signature combined with mucinous component stratifies benefit of anti-CTLA-4 addition to anti-PD-1 in dMMR/MSI-H metastatic colorectal cancer.

From clusters to clinic: An 8-gene signature combined with mucinous component stratifies benefit of anti-CTLA-4 addition to anti-PD-1 in dMMR/MSI-H metastatic colorectal cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 08, 2026

Case #7. HER2 status and colorectal cancer

Case #7. HER2 status and colorectal cancer

Journal: Annales de pathologie

Published: November 24, 2025

Case #6. Adenocarcinoma with a dMMR phenotype

Case #6. Adenocarcinoma with a dMMR phenotype

Journal: Annales de pathologie

Published: November 24, 2025

Histoseminar updates for diagnostic practice and therapeutic targeting of colorectal cancer in 2025

Histoseminar updates for diagnostic practice and therapeutic targeting of colorectal cancer in 2025

Journal: Annales de pathologie

Published: November 16, 2025

Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancer.

Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancer.

Journal: Molecular oncology

Published: September 19, 2025

Efficacy of immunotherapy in gastrointestinal (GI) tumors with mismatch repair deficient (MMRd) unusual phenotype: an AGEO real-world study.

Efficacy of immunotherapy in gastrointestinal (GI) tumors with mismatch repair deficient (MMRd) unusual phenotype: an AGEO real-world study.

Journal: Journal for immunotherapy of cancer

Published: September 14, 2025

Molecular endoscopy with next-generation sequencing improves diagnosis of cholangiocarcinoma in patients with extrahepatic biliary strictures.

Molecular endoscopy with next-generation sequencing improves diagnosis of cholangiocarcinoma in patients with extrahepatic biliary strictures.

Journal: JHEP reports : innovation in hepatology

Published: September 02, 2025

Showing 1-12 of 92

Last Updated: 09/26/2026